← Leaderboards
Ulrich P Jorde
Columbia University Health Sciences
$2,127,953
Attributed
$2,127,953
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $402.5K · FY2007–10$500K$375K$250K$125K$0
'07
'08
'09
'10
Funding mix
By agency
NIH$2,127,953 · 3
By mechanism
R01$1,610,000 · 1
K23$516,564 · 1
M01$1,389 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Steven O Marx$28,353,977
- Pam R. Factor-Litvak$12,428,506
- Stuart D Katz$171,255,562
- Kenneth P Olive$11,212,298
- Jared S Kushner$827,280
Others in their field
Top investigators on “Angiotensin Receptor”
- Pedro A. Jose · George Washington University$17,870,479
- Mohan K. Raizada · University Of Florida$17,824,014
- David M Pollock · University Of Alabama At Birmingham$17,036,617
- Nancy Joan Brown · Vanderbilt University$16,298,789
- Robert J Lefkowitz · Duke University$15,440,480
- Bruce M Psaty · University Of Washington$15,363,450
Research focus
Angiotensin ReceptorClinical ResearchHuman SubjectHuman Therapy EvaluationAngiotensin IiFutureExhibitsGlucoseAttenuationCombination ChemotherapyAcuteBlood Plasma VolumeBlood VesselsAngiotensins3-NitrotyrosineCholesterolAttenuatedAngiotensin-Converting Enzyme InhibitorsCardiomyopathiesDouble-Blind MethodDown-RegulationDrug ControlsAce InhibitorsExercise
Grant awards (9)
Lipoprotein Utilization and Oxidation in CHF$402,500
R01 · FY2010 · HL · contact PI
Lipoprotein Utilization and Oxidation in CHF$402,500
R01 · FY2009 · HL · contact PI
Lipoprotein Utilization and Oxidation in CHF$402,500
R01 · FY2008 · HL · contact PI
Lipoprotein Utilization and Oxidation in CHF$402,500
R01 · FY2007 · HL · contact PI
LOX-1 Protocol$1,389
M01 · FY2004 · RR
LEVEL OF ACE INHIBITION IN HEART FAILURE$129,141
K23 · FY2003 · HL
LEVEL OF ACE INHIBITION IN HEART FAILURE$129,141
K23 · FY2002 · HL
LEVEL OF ACE INHIBITION IN HEART FAILURE$129,141
K23 · FY2001 · HL
LEVEL OF ACE INHIBITION IN HEART FAILURE$129,141
K23 · FY2000 · HL